H.R. 9090 · 117th Congress
Diane Powis Ovarian Cancer Testing Access Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
DeanSponsorNo cosponsors.
This bill provides for Medicare coverage of multimarker tests related to ovarian cancer (i.e., tests that evaluate more than one tumor marker with respect to ovarian cancer).
What it does: CRS summary · Introduced in House · Sep 30, 2022
Diane Powis Ovarian Cancer Testing Access Act
This bill provides for Medicare coverage of multimarker tests related to ovarian cancer (i.e., tests that evaluate more than one tumor marker with respect to ovarian cancer).
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Diane Powis Ovarian Cancer Testing Access Act
Latest action (Oct 3, 2022): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Sep 30, 2022
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.